Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anastasios Dimitrios Roumeliotis, M.D.

Concepts (58)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug-Eluting Stents320207530.610 Why?
Lipoproteins, HDL120206370.550 Why?
Coronary Artery Disease5202064540.370 Why?
Registries4202080770.300 Why?
Absorbable Implants220183420.260 Why?
Coronary Thrombosis220184940.250 Why?
Stents4202032760.240 Why?
Hemorrhage4202034610.190 Why?
Anaphylaxis220187460.190 Why?
Aortic Valve Stenosis2202019410.160 Why?
New York120208860.160 Why?
Hirudins120181820.150 Why?
Chlorhexidine120181620.150 Why?
Radial Artery120181940.140 Why?
Vascular Patency120188850.130 Why?
Coronary Aneurysm120172370.130 Why?
Intraoperative Complications2201811880.120 Why?
Arterial Occlusive Diseases120187930.110 Why?
Coronary Angiography3201845670.100 Why?
Diabetes Mellitus2202057240.100 Why?
Heart Valve Prosthesis1202014860.100 Why?
Anemia1202014990.100 Why?
Tissue Scaffolds120179570.090 Why?
Perioperative Care120179970.090 Why?
Heart Valve Prosthesis Implantation1202015270.090 Why?
Platelet Aggregation Inhibitors2202030670.080 Why?
Thrombosis2201829660.070 Why?
Risk Factors72020721450.070 Why?
Survival Rate12020127730.070 Why?
Peptide Fragments1201850950.070 Why?
Prognosis22020290100.060 Why?
Incidence12020209280.050 Why?
Prosthesis Design2202021100.050 Why?
Aortic Valve2202019110.050 Why?
Follow-Up Studies12020390040.040 Why?
Treatment Outcome52020629660.040 Why?
Humans1520207420880.040 Why?
Aged420201629440.030 Why?
Shock120183180.030 Why?
Antithrombins120183040.030 Why?
Vincristine1201710360.030 Why?
Retrospective Studies22020770980.030 Why?
Risk Assessment32020233200.030 Why?
Middle Aged420202131270.030 Why?
Fatal Outcome1201818490.030 Why?
Female620203795920.030 Why?
Tyrosine1201714600.030 Why?
Ticlopidine120178990.030 Why?
Antigens1201714620.030 Why?
Male420203495380.020 Why?
Recombinant Proteins1201866080.020 Why?
Recurrence1202083330.020 Why?
Patient Selection1202042140.020 Why?
Sex Factors12020103920.020 Why?
Aspirin1201732780.020 Why?
Aged, 80 and over22020576830.020 Why?
Prevalence12020151940.010 Why?
Time Factors12020400540.010 Why?
Roumeliotis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (58)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.